Peritonsillar Abscess Treatment Market

Peritonsillar abscess (PTA) also called quinsy. In this condition, the infection spreads behind tonsillitis. It occurs when there is pus collection and the infection spreads beyond the tonsils into the neck and chest. These swollen tissues cause airway blockage. Diagnosis can be done clinically, by laboratory investigations and by Radiological investigation. Treatment can be done using selective antibiotics and the best is by removing the abscess material. The intravenous penicillin is the choice of therapy, and hence the wide scope for the growth can be taken into consideration. The ultrasonography and computed tomographic scanning are used in the diagnosis of the disease. While needle aspiration is a gold standard method. After performing needle aspiration appropriate antibiotics therapy must be given. As Peritonsillar abscess is common in the people of young age group there is huge scope for Peritonsillar abscess treatment market. If the abscess cannot be managed by the antibiotics treatment then various surgical procedures such as needle aspiration, incision and drainage can be used. After needle aspiration, appropriate antibiotics therapy must be initiated.
Peritonsillar Abscess Treatment Market contains market size and forecasts of Peritonsillar Abscess Treatment in Global, including the following market information:
Global Peritonsillar Abscess Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Peritonsillar Abscess Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Peritonsillar Abscess Treatment include Pfizer Inc., Merck & Co., Johnson & Johnson, Abbott Laboratories, Eli Lilly & Co., GlaxoSmithKline Plc., Bayer AG, Allergan plc. and F. Hoffmann-La Roche AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peritonsillar Abscess Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peritonsillar Abscess Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Peritonsillar Abscess Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Steroids Drugs
Analgesics Drugs
Oral Suction System
Reciprocating Procedure Device
Tonsillectomy Device
Global Peritonsillar Abscess Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Peritonsillar Abscess Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Mail Order Pharmacies
Drug Stores
Other
Global Peritonsillar Abscess Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Peritonsillar Abscess Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peritonsillar Abscess Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Peritonsillar Abscess Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Merck & Co.
Johnson & Johnson
Abbott Laboratories
Eli Lilly & Co.
GlaxoSmithKline Plc.
Bayer AG
Allergan plc.
F. Hoffmann-La Roche AG
Sun Pharmaceutical Industries Limited
Hindustan Antibiotics Limited
Alembic Ltd.
Nicholas Piramal India Ltd.